Portfolio

Personalized treatment plans and cross-functional coordinated care for members digital care infrastructure.

Most accurate and validated mobile software for measuring stability, including concussion assessments.

Direct contracting to reduce employer healthcare expenses, improve patient outcomes, and simplify navigation for employees.

Industry-leading precision micro-optical assemblies and devices for medical and defense applications.

Category-defining quality in non-emergency medical transportation (NEMT) brokerage, fleet management, and point-to-point patient transportation.

Hospital-grade mobile EKGs and ECGs, including 12-lead diagnostics, automated algorithms, and remote care connectivity.

Next generation maternal care coordination, digital health integration, and remote monitoring for expecting and new mothers.

Novel pharmaceutical treatment for relapsing-remitting multiple sclerosis and endometriosis.

Evidence-based fertility, hormone, and longevity care personalized for every stage of reproductive health.

Comprehensive remote diagnostics and monitoring for health systems and providers using mobile devices.

Development for drugs focused on gastrointestinal ailments, including inflammatory bowel disease and ulcerative colitis.

Near-site and on-site clinics for major employers that allow for improved outcomes, lower costs, and independent network control.

Post-acute therapy centers taking home health care to the next level through standardized care and proximal provider centers.

Lasers and laser systems for precise measurements in life science applications.

Automated preparation for small-batch injectable medication.

Digital scan services to detect, stage, and monitor diabetic retinopathy in the primary diabetes care setting.

Predictive medicine company focused on molecular diagnostics and targeted therapy for cancer.

Life-saving smart alarms for children, heavy sleepers, seniors, and people with hearing loss.

Developing oral treatments for acute and chronic hearing loss to reduce the incidence and severity of permanent hearing disorders.

Novel pharmaceutical treatment for sickle cell crisis via antibody (SelG1) directed against the adhesion molecule P-selectin.

Development of aspartic protease inhibitors, including beta secretase inhibitors, for slowing the progression of Alzheimer’s disease.

1/4

in